The present invention provides synthetic and biocompatible scaffolds for surgical application in joint and/or ligament repair.
[Detail]
We have developed a cost-effective, highly-efficient photocatalyst that is activated using visible light. Our catalyst has potential applications in decontamination and disinfection processes and manufacture of chemicals using renewable energy.
[Detail]
Novel, highly potent peptide inhibitors of the Kv1.3 potassium channel, an emerging target for autoimmune diseases. The Monash peptides offer numerous advantages, including high Kv1.3 selectivity, minimising the potential for off-target side effects, efficacy across a range of experimental models an.....
[Detail]
 |
Monash University researchers have identified and validated a novel anti-fibrosis target - IRAP. Inhibition of this target with the proprietary small molecule lead series completely reversed cardiac and renal fibrosis in clinically relevant disease models. We nows eek a partner to develop novel lead.....
[Detail]
 |
| |< <- | [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] | -> >| |
